Sharlene M Day
Works at
Associate professor
Sources: reporter.nih.gov
Grants and prizes
National Heart, Lung, and Blood Institute
R33, SGLT-inhibitors in patients with hypertrophic cardiomyopathy, R33HL164376, 2023–2027, 14 Sept 2026
National Heart, Lung, and Blood Institute
R61, SGLT-inhibitors in patients with hypertrophic cardiomyopathy, R61HL164376, 2023–2024, 17 Aug 2023
Sources: reporter.nih.gov